Soligenix Receives US Patent for Improved Production of Synthetic Hypericin Composition
Active Ingredient in SGX301 for the Treatment of
Cutaneous T-Cell Lymphoma […]
Active Ingredient in SGX301 for the Treatment of
Cutaneous T-Cell Lymphoma […]
New York City, Oct. 15, 2019 (GLOBE NEWSWIRE) — Co-Diagnostics Plans Product Launch for Emerging Mosquito Threat EEE Virus as Demand Grows New York City, New York – News yesterday from Co-Diagnostics, Inc. (Nasdaq: CODX), a biotech with […]
Key products to be tested, registered and marketed include Insugin for diabetes application, alternative insulin for Alzheimer’s application, and Blood Plasma Derived Products, Human Serum Albumin 20% […]
Generex Biotechnology Corporation is an integrated healthcare holding company with end‐to‐end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. […]
Expansion to include increased royalties and cover additional applications for Company’s technology platform […]
WEST CALDWELL, NJ and TORONTO, ON, Sept. 04, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery […]
VANCOUVER, British Columbia, Aug. 27, 2019 (GLOBE NEWSWIRE) — Scottie Resources Corp. (“Scottie” or the “Company”) (TSXV: SCOT) is excited to share preliminary field observations from the current season’s exploration program on its Scottie Gold […]
Generex Now Owns 99% of Subsidiary Olaregen Therapeutix Generex Satisfies Notes for $138,000 and $900,000 to clear debt NuGenerex Immuno-Oncology Spin-out Evaluating Acquisition of a Hospital Network Completed Audit of Direct-to-Patient Pharmacy Business MIRAMAR, Fla., […]
Salt Lake City, UT, Aug. 14, 2019 (GLOBE NEWSWIRE) — Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today the filing of its […]
MIRAMAR, Fla., Aug. 08, 2019 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (OTCQB:GNBT) today announced that Joe Moscato, the company’s President & Chief Executive Officer conducted an interview with the Wall Street Analyzer, which is available […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com